These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 35864546)
1. Homologous recombination deficiency (HRD) score in aggressive prostatic adenocarcinoma with or without intraductal carcinoma of the prostate (IDC-P). Zhu S; Zhao J; Nie L; Yin W; Zhang Y; Zhao F; Ni Y; Zhang X; Wang Z; Dai J; Liu Z; Chen J; Zeng Y; Wang Z; Sun G; Liang J; Zhao X; Zhu X; Tao R; Yang J; He B; Chen N; Shen P; Zeng H BMC Med; 2022 Jul; 20(1):237. PubMed ID: 35864546 [TBL] [Abstract][Full Text] [Related]
2. Cribriform and intraductal prostate cancer are associated with increased genomic instability and distinct genomic alterations. Böttcher R; Kweldam CF; Livingstone J; Lalonde E; Yamaguchi TN; Huang V; Yousif F; Fraser M; Bristow RG; van der Kwast T; Boutros PC; Jenster G; van Leenders GJLH BMC Cancer; 2018 Jan; 18(1):8. PubMed ID: 29295717 [TBL] [Abstract][Full Text] [Related]
3. Genomic and Evolutionary Characterization of Concurrent Intraductal Carcinoma and Adenocarcinoma of the Prostate. Zhao J; Xu N; Zhu S; Nie L; Zhang M; Zheng L; Cai D; Sun X; Chen J; Dai J; Ni Y; Wang Z; Zhang X; Liang J; Chen Y; Hu X; Pan X; Yin X; Liu H; Zhao F; Zhang B; Chen H; Miao J; Qin C; Zhao X; Yao J; Liu Z; Liao B; Wei Q; Li X; Liu J; Gao AC; Huang H; Shen P; Chen N; Zeng H; Sun G Cancer Res; 2024 Jan; 84(1):154-167. PubMed ID: 37847513 [TBL] [Abstract][Full Text] [Related]
4. Patient-derived xenografts reveal that intraductal carcinoma of the prostate is a prominent pathology in BRCA2 mutation carriers with prostate cancer and correlates with poor prognosis. Risbridger GP; Taylor RA; Clouston D; Sliwinski A; Thorne H; Hunter S; Li J; Mitchell G; Murphy D; Frydenberg M; Pook D; Pedersen J; Toivanen R; Wang H; Papargiris M; Lawrence MG; Bolton DM Eur Urol; 2015 Mar; 67(3):496-503. PubMed ID: 25154392 [TBL] [Abstract][Full Text] [Related]
5. Establishing the homologous recombination score threshold in metastatic prostate cancer patients to predict the efficacy of PARP inhibitors. Zhao D; Wang A; Li Y; Cai X; Zhao J; Zhang T; Zhao Y; Dong Y; Zhou F; Li Y; Wang J J Natl Cancer Cent; 2024 Sep; 4(3):280-287. PubMed ID: 39281716 [TBL] [Abstract][Full Text] [Related]
7. Distinction between intraductal carcinoma of the prostate (IDC-P), high-grade dysplasia (PIN), and invasive prostatic adenocarcinoma, using molecular markers of cancer progression. Dawkins HJ; Sellner LN; Turbett GR; Thompson CA; Redmond SL; McNeal JE; Cohen RJ Prostate; 2000 Sep; 44(4):265-70. PubMed ID: 10951489 [TBL] [Abstract][Full Text] [Related]
8. [The subgroup analysis of the prognostic value of the intraductal carcinoma of the prostate in patients with metastatic prostate cancer]. Zhao JG; Nie L; Chen XQ; Chen N; Zeng H Zhonghua Wai Ke Za Zhi; 2019 Jun; 57(6):422-427. PubMed ID: 31142066 [No Abstract] [Full Text] [Related]
9. Circulating tumour DNA reveals genetic traits of patients with intraductal carcinoma of the prostate. Zhao J; Sun G; Zhu S; Dai J; Chen J; Zhang M; Ni Y; Zhang H; Shen P; Zhao X; Zhang B; Pan X; Nie L; Yin X; Liang J; Zhang X; Wang Z; Zhu X; Liao B; Liu Z; Armstrong CM; Gao AC; Huang H; Chen N; Zeng H BJU Int; 2022 Mar; 129(3):345-355. PubMed ID: 34185954 [TBL] [Abstract][Full Text] [Related]
10. Intraductal carcinoma of the prostate in prostate biopsy samples: correlation with aggressive pathological features after radical prostatectomy and prognostic value in high-risk prostate cancer. Zhu S; Zhao JG; Chen JR; Liu ZH; Sun GX; Wang ZP; Ni YC; Dai JD; Shen PF; Zeng H Asian J Androl; 2020; 22(5):519-525. PubMed ID: 31710002 [TBL] [Abstract][Full Text] [Related]
11. Grading Intraductal Carcinoma of the Prostate; ISUP versus GUPS Recommendations. Shahid A; Mushtaq S; Maqbool H; Hassan U; Hussain M; Syed M J Coll Physicians Surg Pak; 2023 Apr; 33(4):396-399. PubMed ID: 37190710 [TBL] [Abstract][Full Text] [Related]
12. GBX2 Methylation Is a Novel Prognostic Biomarker and Improves Prediction of Biochemical Recurrence Among Patients with Prostate Cancer Negative for Intraductal Carcinoma and Cribriform Architecture. Jeyapala R; Savio AJ; Olkhov-Mitsel E; Kamdar S; Zhao F; Cuizon C; Liu RSC; Zlotta A; Fleshner N; van der Kwast T; Bapat B Eur Urol Oncol; 2019 May; 2(3):231-238. PubMed ID: 31200836 [TBL] [Abstract][Full Text] [Related]
13. Disease-specific survival of patients with invasive cribriform and intraductal prostate cancer at diagnostic biopsy. Kweldam CF; Kümmerlin IP; Nieboer D; Verhoef EI; Steyerberg EW; van der Kwast TH; Roobol MJ; van Leenders GJ Mod Pathol; 2016 Jun; 29(6):630-6. PubMed ID: 26939875 [TBL] [Abstract][Full Text] [Related]
14. Heterogeneous clinicopathological features of intraductal carcinoma of the prostate: a comparison between "precursor-like" and "regular type" lesions. Miyai K; Divatia MK; Shen SS; Miles BJ; Ayala AG; Ro JY Int J Clin Exp Pathol; 2014; 7(5):2518-26. PubMed ID: 24966964 [TBL] [Abstract][Full Text] [Related]
15. RNA-Based Homologous Recombination Deficiency Signature Detects Homologous Recombination Deficiency-RNA+ Patients With and Without Homologous Recombination Repair Gene Pathogenic Alterations in Men With Prostate Cancer. Brown LC; Zhu J; Mauer E; Thiede SN; Macera L; Stein MM; Taxter T; Raghavan D; Burgess EF JCO Precis Oncol; 2023 Sep; 7():e2300378. PubMed ID: 38061006 [TBL] [Abstract][Full Text] [Related]
16. A Prostate Cancer "Nimbosus": Genomic Instability and SChLAP1 Dysregulation Underpin Aggression of Intraductal and Cribriform Subpathologies. Chua MLK; Lo W; Pintilie M; Murgic J; Lalonde E; Bhandari V; Mahamud O; Gopalan A; Kweldam CF; van Leenders GJLH; Verhoef EI; Hoogland AM; Livingstone J; Berlin A; Dal Pra A; Meng A; Zhang J; Orain M; Picard V; Hovington H; Bergeron A; Lacombe L; Fradet Y; Têtu B; Reuter VE; Fleshner N; Fraser M; Boutros PC; van der Kwast TH; Bristow RG Eur Urol; 2017 Nov; 72(5):665-674. PubMed ID: 28511883 [TBL] [Abstract][Full Text] [Related]
18. Atypical intraductal proliferation and intraductal carcinoma of the prostate on core needle biopsy: a comparative clinicopathological and molecular study with a proposal to expand the morphological spectrum of intraductal carcinoma. Shah RB; Yoon J; Liu G; Tian W Histopathology; 2017 Nov; 71(5):693-702. PubMed ID: 28570007 [TBL] [Abstract][Full Text] [Related]
19. SLC26A4 correlates with homologous recombination deficiency and patient prognosis in prostate cancer. Luo C; Liu Z; Gan Y; Gao X; Zu X; Zhang Y; Ye W; Cai Y J Transl Med; 2022 Jul; 20(1):313. PubMed ID: 35836192 [TBL] [Abstract][Full Text] [Related]
20. Transcriptomic Features of Cribriform and Intraductal Carcinoma of the Prostate. Lone Z; Benidir T; Rainey M; Nair M; Davicioni E; Gibb EA; Williamson S; Gupta S; Chaim Ornstein M; Tendulkar R; Weight C; Nguyen JK; Klein EA; Mian OY Eur Urol Focus; 2022 Nov; 8(6):1575-1582. PubMed ID: 35662504 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]